1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ro 5-4864 in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ro 5-4864) | Trials (ro 5-4864) | Recent Studies (post-2010) (ro 5-4864) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 593 | 0 | 54 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | ro 5-4864 (IC50) |
|---|---|---|---|
| Translocator protein | Rattus norvegicus (Norway rat) | 0.034 | |
| Translocator protein | Mus musculus (house mouse) | 0.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, K; Hong, T; Levy, JV | 1 |
| Casals-Stenzel, J; Weber, KH | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ro 5-4864
| Article | Year |
|---|---|
The benzodiazepine receptor ligands RO 5-4864 and RO 15-1788 do not block the inhibition of PAF-induced platelet aggregation seen with the hetrazepine WEB2086.
Topics: Adenosine Triphosphate; Animals; Azepines; Benzodiazepinones; Blood Platelets; Female; Flumazenil; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, GABA-A; Triazines; Triazoles | 1989 |
Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity.
Topics: Animals; Anti-Anxiety Agents; Azepines; Benzodiazepinones; Central Nervous System; Flumazenil; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Receptors, GABA-A; Tidal Volume; Triazolam | 1987 |